Salva R. Yurista

Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin Improves Cardiac Function in Non-Diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction

Salva R. Yurista, Herman H.W. Silljé, Silke U. Oberdorf‐Maass et al. · European Journal of Heart Failure · 2019 · 312 citations · Full text

Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure

Salva R. Yurista, Timothy Matsuura, Herman H.W. Silljé et al. · Circulation Heart Failure · 2020 · 142 citations · Full text

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes

Oriol Iborra‐Egea, Evelyn Santiago‐Vacas, Salva R. Yurista et al. · JACC Basic to Translational Science · 2019 · 93 citations · Full text

SGLT2 Inhibitors and Ketone Metabolism in Heart Failure

Huitzilihuitl Saucedo‐Orozco, Suzanne N. Voorrips, Salva R. Yurista et al. · Journal of Lipid and Atherosclerosis · 2022 · 76 citations · Full text

Metabolic Syndrome, Cardiomyopathy, Heart Failure +12

A soft robotic sleeve mimicking the haemodynamics and biomechanics of left ventricular pressure overload and aortic stenosis

Luca Rosalia, Çağlar Öztürk, Jaume Coll‐Font et al. · Nature Biomedical Engineering · 2022 · 38 citations · Full text

Mechanobiology, Heart Failure, Engineering +13